Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorOslo University Hospital
About this trial
The GaP study is designed to close important knowledge gaps by:
1. exploring placental health and cellular ageing in GDM and the association with neonatal outcome 2. evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
Eligibility criteria
Qualifiers
Pregnant women >18 years with GDM giving birth at Oslo University hospital Ullevål.
Control group of gestational age matched euglycemic, normotensive pregnancies
Disqualifiers
reduced fetal movements,
epilepsy
thyroidea dysfunction
hypertensive disorder of pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
350 Participants
are grouped into 2 trial groupsSponsors and collaborators
Oslo University Hospital
Lead sponsor
Norwegian SIDS and Stillbirth Society
Collaborator
Source ClinicalTrials.gov